These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23533097)

  • 1. Progesterone supplementation in women with otherwise unexplained recurrent miscarriages.
    Hussain M; El-Hakim S; Cahill DJ
    J Hum Reprod Sci; 2012 Sep; 5(3):248-51. PubMed ID: 23533097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.
    Coomarasamy A; Harb HM; Devall AJ; Cheed V; Roberts TE; Goranitis I; Ogwulu CB; Williams HM; Gallos ID; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Crosfill F; Deb S; Duncan WC; Ewer A; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden MA; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Middleton LJ
    Health Technol Assess; 2020 Jun; 24(33):1-70. PubMed ID: 32609084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.
    Coomarasamy A; Devall AJ; Brosens JJ; Quenby S; Stephenson MD; Sierra S; Christiansen OB; Small R; Brewin J; Roberts TE; Dhillon-Smith R; Harb H; Noordali H; Papadopoulou A; Eapen A; Prior M; Di Renzo GC; Hinshaw K; Mol BW; Lumsden MA; Khalaf Y; Shennan A; Goddijn M; van Wely M; Al-Memar M; Bennett P; Bourne T; Rai R; Regan L; Gallos ID
    Am J Obstet Gynecol; 2020 Aug; 223(2):167-176. PubMed ID: 32008730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent MiscarriageGreen-top Guideline No. 17.
    Regan L; Rai R; Saravelos S; Li TC;
    BJOG; 2023 Nov; 130(12):e9-e39. PubMed ID: 37334488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages.
    Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Bender Atik R; Bloemenkamp KW; Brady R; Briley AL; Cavallaro R; Cheong YC; Chu JJ; Eapen A; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Ross JA; Sharpe L; Stewart J; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
    N Engl J Med; 2015 Nov; 373(22):2141-8. PubMed ID: 26605928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage.
    Yan J; Liu F; Yuan X; Saravelos SH; Cocksedge K; Li TC
    Reprod Biomed Online; 2013 Feb; 26(2):138-41. PubMed ID: 23273755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
    Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
    Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
    Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth.
    Kolanska K; Dabi Y; Dechartres A; Cohen J; Ben Kraiem Y; Selleret L; Mathieu d'Argent E; Placais L; Cheloufi M; Johanet C; Rosefort A; Bornes M; Suner L; Delhommeau F; Ledée N; Chabbert Buffet N; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
    Am J Reprod Immunol; 2021 Aug; 86(2):e13425. PubMed ID: 33772927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.
    Plaçais L; Kolanska K; Kraiem YB; Cohen J; Suner L; Bornes M; Sedille L; Rosefort A; D'Argent EM; Selleret L; Abisror N; Johanet C; Buffet NC; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():100-104. PubMed ID: 32592916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study.
    Field K; Murphy DJ
    Hum Reprod; 2015 May; 30(5):1239-45. PubMed ID: 25759495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
    Tempfer CB; Kurz C; Bentz EK; Unfried G; Walch K; Czizek U; Huber JC
    Fertil Steril; 2006 Jul; 86(1):145-8. PubMed ID: 16716321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial.
    Ismail AM; Abbas AM; Ali MK; Amin AF
    J Matern Fetal Neonatal Med; 2018 Feb; 31(3):388-394. PubMed ID: 28114846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational age of pregnancy loss in women with unexplained recurrent miscarriage.
    Ticconi C; Giuliani E; Sorge R; Patrizi L; Piccione E; Pietropolli A
    J Obstet Gynaecol Res; 2016 Mar; 42(3):239-45. PubMed ID: 26663368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
    Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage.
    van den Boogaard E; Cohn DM; Korevaar JC; Dawood F; Vissenberg R; Middeldorp S; Goddijn M; Farquharson RG
    Fertil Steril; 2013 Jan; 99(1):188-192. PubMed ID: 23043688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous first trimester miscarriage rates per woman among parous women with 1 or more pregnancies of 24 weeks or more.
    Cohain JS; Buxbaum RE; Mankuta D
    BMC Pregnancy Childbirth; 2017 Dec; 17(1):437. PubMed ID: 29272996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.